… record-high medical cannabis revenue, adjusted EBITDA and positive … an impact outside of Q1.” Focused On Medical, … revenue and nearly 90% of its gross profit. "All of the profitability … "Because these are pharmaceutical products, we believe that …

… sales and, in turn, profits," said Humayun Rashid, … 613 crore recorded in the first quarter of 2022. This marks … profit in the quarter at Tk 633 crore, followed by Square Pharmaceuticals … Eastern Bank all reported solid profit growth during the quarter. …

… end-2025 or by the first quarter of 2026. Managing director Zulkifli … the first quarter of 2026,” he said at a press conference after Pharmaniaga … 2024, the group recorded a profit after tax (PAT) of RM133 … 2025 about RM4 billion in revenue with a PAT of RM60 …

… revenue collection and check smuggling. In the first quarter … declared and unwholesome pharmaceutical and controlled products … and unwholesome pharmaceutical and controlled products … sustained through conscientious revenue collection activities. Accordingly …

KUALA LUMPUR, June 18 — Life insurance companies say they are making losses on their health insurance portfolios despite perceived overall profits, with claims far outpacing premiums in recent years. This led to insurers recording medical insurance …

… first quarter of 2025, the total value of deals involving Chinese pharmaceutical … steep drops in revenue, pharmaceutical giants are shifting … deals remain highly profitable for Chinese companies, … partnerships with major pharmaceutical companies is intense, …

ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial …

… because of the US drug companies’ ability to directly advertise … revenue to advertising and media companies, as well as the US pharmaceutical … for AbbVie in the first quarter of 2025. “We … weather technology. “Restricting pharmaceutical ads would have serious …

… $0.8 million in Q1 2024 Cash position strengthened … May 3, 2025. “Our first-quarter performance demonstrates consistent execution of … creation for shareholders. Revenues are up, gross profit is up, and … ,000 grocery stores and pharmacies, over 1,500 convenience …

EINDHOVEN, the Netherlands, June 17, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord …